We examined whether the changes in clinical practice with time correlated with the changes in the 90-day mortality following pneumonectomy.
INTRODUCTION
Prior to 1931, all attempts to perform pneumonectomy in humans proved to be fatal because of haemorrhage, sepsis and lack of a durable bronchial closure. Pneumonectomy has since become a standard procedure with the resolution of the technical problems of that time [1] . In the more recent era, indications for pneumonectomy are diminishing as lesser resections have demonstrated similar efficacy with less morbidity. Today, pneumonectomy is considered a high-risk procedure and its utility is being questioned [2] .
Pneumonectomy may yet be unavoidable because of anatomical and technical considerations. Patient selection and postoperative care have also progressively improved over the last 30 years, especially in patients with non-small-cell lung cancer (NSCLC). In this setting, the impact of pneumonectomy on long-term survival remains controversial and likely hinges on early postoperative mortality [3] . Our goals were (i) to describe the overall postoperative morbidity and mortality following pneumonectomy, and then to analyse the results according to the diagnosis, side and time-period; and (ii) to focus on patients with NSCLC, and to analyse their postoperative course according to the type of resection, time-period and induction strategy.
PATIENTS AND METHODS

Patients
The clinical records of patients who underwent a pneumonectomy from January 1980 to December 2009 in Georges Pompidou European Hospital (Paris) and Cedar Surgery Centre (Bois Guillaume) were retrospectively reviewed. Lung tumour data have been prospectively entered since April 1984. The preoperative work-up included chest X-ray, bronchoscopy, computed tomography (CT) scan of the chest since 1984, spirometry, lung perfusion scan and echocardiography. When pneumonectomy was performed for malignant disease, a thorough search for distant metastases, including positron emission tomography scan since 2003, was performed.
Surgery
All pneumonectomies were performed via posterolateral thoracotomy. Hand-sewn bronchial closure was generally performed, but some cases underwent stapler closure and running suture depending on surgeon's preference. After undergoing pneumonectomy, all patients were extubated in the operating theatre and transferred to a postanaesthesia or intensive care unit. When the postoperative course was uneventful, patients stayed on the surgical ward for a total of 14 days, and the pneumonectomy cavity was emptied before discharge.
Postoperative course
We recorded non-lethal postoperative complications occurring during the first month (30-day morbidity), postoperative deaths occurring during the first month (30-day mortality) and postoperative deaths occurring during the first 3 months (90-day mortality). Complications consisted of empyema, broncho-pleural fistula (BPF), pneumonia, respiratory failure, acute respiratory distress syndrome, pulmonary emboli, myocardial infarction, cardiac arrhythmia, stroke, recurrent nerve palsy, haemorrhage, chylothorax, parietal infection and miscellaneous. The postoperative course was analysed according to patients' sex, age, smoking habits, pneumonectomy indication, side, type, bronchial closure, bronchial stump coverage and time-period (1980-1989, 1990-1999 and 2000-2009) . Tumours of the lung were classified according to the World Health Organization histological classification [4] . Lung cancers were classified according to the new tumor nodes metastasis classification [5] .
Statistical analysis
The study was approved by our Thoracic Surgery Society Ethics Committee that waived need for informed consent. Continuous variables were reported as mean ± standard deviation, and compared using Student's t-test. Categorical variables were reported as count and proportions, and compared using the χ 2 test. Prognostic analysis of 90-day mortality was performed using logistic regression. All data analyses were conducted with the two-sided test: a P-valueof <0.05 was considered as statistically significant. The statistical software used for the analysis was statistiques epidémiologie médecine (Anticancer Centre Jean Perrin, Clermont-Ferrand, France) [6] .
RESULTS
Study group
In total, 2064 pneumonectomies were performed during the study period and account for the study group described in Table 1 . The 90-day mortality was 8.0%, the 30-day morbidity was 21.4%. Pneumonectomy was extended beyond the lung in 527 patients (25.5%). Extended pneumonectomy consisted of pleuro-pneumonectomy in 39 patients presenting with mesothelioma and in 42 of the 88 patients presenting with non-tumoural disease (47.7%). In the latter group, pleuro-pneumonectomy was extended to the pericardium in 24 and to the diaphragm in 37 cases. When comparing regular with extended pneumonectomies, the 30-day morbidity was significantly higher in extended pneumonectomy (26.6 vs 31.4%, P = 0.049), but frequency of BPF (2.5 vs 2.8%, respectively, P = 0.69) and 30-day mortality (6.4 vs 5.4%, respectively, P = 0.42) were not.
Side
There were 948 right (45.9%) and 1116 left pneumonectomies (54.1%) in the study group. Comparison between both sides is given in Table 2 . The total frequency of complications was similar, but postoperative deaths were more frequent on the right side whereas non-lethal complications were more frequent on the left side. On the right side, BPF was more frequent in patients with bronchial stump coverage than in patients without (6.3 vs 3.3%, respectively, P = 0.026). On the left side, the frequency of BPF was not significantly different in patients with or without bronchial stump coverage (1.2 vs 1.9%, respectively, P = 0.30).
Diagnosis
We then examined the postoperative course according to the underlying diagnosis as presented in Table 3 . The 90-day mortality was lower in patients with non-tumoural disease (4.5%) and in patients with NSCLC (7.8%) than in patients with mesothelioma (10.3%) and other tumoural disease (13.6%, P = 0.0035). This significant difference in 90-day mortality according to diagnosis was seen on the right but not on the left side. The rate of bronchial stump coverage was lower in patients with NSCLC (P <0.001) and the rate of empyema without fistula was higher in patients with mesothelioma (P = 0.0066).
Time-period
The frequency of postoperative complications increased over time, as given in Table 4 . This increase was mainly due to the constant increase in the rate of postoperative cardiac arrhythmias, which was found for both sides. However, 30-and 90-day mortality rates remained stable over time, regardless of the side.
Prognostic analysis
We analysed the factors predicting overall 90-day mortality in Table 5 . In univariate analysis, older age, right-sided resection, absence of bronchial stump coverage, NSCLC with T3-T4 and N2 extension were associated with adverse outcome. In multivariate analysis, age, time-period, side of resection, T and N extension were independent prognostic factors.
Pneumonectomy for non-small-cell lung cancer
The postoperative course following pneumonectomy for NSCLC was analysed over the three time-periods, and compared with the postoperative course following lobectomy for NSCLC in Table 6 . Interestingly, the 90-day mortality following induction therapy and pneumonectomy decreased over time (P = 0.057 for the comparison between the three decades) and dropped from 21.9% in the 1980s to 8.2% in the 2000s (P = 0.038); while such decrease was not found in case of no induction and pneumonectomy (respectively P = 0.34; 11.1 and 12.3%, P = 0.66), induction and lobectomy (P = 0.24; 0 and 5.2%, P = 0.81), and no induction and lobectomy (P = 0.84; 5.5 and 5.4%, P = 0.94). When 30-day mortality was estimated according to the pathological stage, no significant difference was found between earlier and more advanced diseases 
COMMENTS
In this study of the postoperative course following pneumonectomy in a surgical series of more than 2000 patients, we found that the frequency of postoperative complications increased over time, mainly due to a growing frequency of cardiac arrhythmias. Concomitantly, multivariate analysis revealed an improvement in the 90-day mortality of the most recent time-period, mostly due to the improvement in 90-day mortality after induction therapy followed by pneumonectomy for NSCLC. Over the last 50 years, the mortality rates after pneumonectomy have been reported to vary from 3 to 30% according to population subgroups and underlying diseases [7] . The non-lethal morbidity rate has also been reported to vary greatly, from 15 to 51%, with major complications being atelectasis, cardiac arrhythmias, pneumonia, respiratory failure, haemothorax, empyema and bronchopleural fistula [7] . Nowadays, the mortality and morbidity rates are reported to average from 5 to 7% and 30 to 40%, respectively [8] [9] [10] [11] [12] [13] [14] . Kalathiya et al. [14] reported major postoperative complications in 39 out of 100 consecutive pneumonectomies, with atrial fibrillation being the most common complications, and occurring in 26 patients. Mansour et al. [9] showed that postoperative atrial fibrillation was more common in the male gender and in age 70 and older. It is worth noticing that male sex [10, 13, 15, 16] and age [10, 13, 16] have also been identified as independent risk factors for postoperative morbidity and mortality following pneumonectomy. Thus, the increasing number of postoperative arrhythmias and overall morbidity identified in our series may be the result of an ageing population, together with a potential diagnosis bias leading to more frequent treatment of benign postoperative arrhythmias.
In our series, postoperative morbidity did not differ between pathologies requiring pneumonectomy. Similarly, Bouchikh et al. [15] reported acceptable rates of mortality and empyema after pneumonectomy for benign disease. On the contrary, Shapiro et al. [10] found benign lung disease to be associated with an adverse outcome, and Shiraishi et al. [17] reported a postoperative mortality of 8.5% following extrapleural pneumonectomy for thoracic empyema. In the particular case of mesothelioma, the rate of postoperative mortality was not significantly different in our series, whereas the rate of empyema was. In the series published by Sugarbaker et al. [18] , the mortality rate was 3.4%, and complications included more atrial fibrillation than empyema and BPF. In the series published by Schipper et al. [19] , the 30-day mortality rate was 6.3% and not associated with the extent of the resection, but the major complication rate was 51% and significantly higher than in patients having any other procedure. Similarly, Rena et al. [20] reported that for mesothelioma patients, extrapleural pneumonectomy was associated with a higher postoperative morbidity than pleurectomy or decortication, whereas postoperative mortality remained low for the three procedures.
All authors agree that postoperative mortality is more frequent following right pneumonectomy [9, 12-14, 21, 22] . Reviewing 9746 pneumonectomies from the surveillance, epidemiology, and end results program-database, Fernandez et al. [21] reported 30 and 90-day mortality rates of 8 and 16% for right pneumonectomies and 4 and 9% for left pneumonectomies, a highly significant difference. In a meta-analysis, Kim et al. [22] reported 30-day mortality rates of 11% for right and 5% for left pneumonectomies, and 90-day mortality rates of 20% for right and 9% for left pneumonectomies. According to this latter study, pulmonary complications were the most common cause of postoperative deaths [22] . The link between right pneumonectomy and postoperative pulmonary complications may be due to the functional predominance of the ablated lung, or to the length and position of the left main bronchus that may interfere with adequate postoperative cough, thus exposing a smaller lung to a more arduous postoperative course. We also observed that postoperative deaths were more frequent on the right but complications without death were more frequent on the left. Curiously, the total value of morbidity and mortality was the same on both sides. The role of induction therapy is still unclear. Some series report high mortality rate following neoadjuvant therapy particularly following right pneumonectomy [14] . Some other series report higher mortality rate following neoadjuvant therapy whatever the side of the resection. For Bernard et al. [13] , preoperative radiation significantly impacts morbidity, whereas preoperative chemotherapy significantly impacts mortality. Furthermore, Shapiro et al. [10] reported that patients with lung carcinoma receiving induction chemoradiotherapy were more at risk for major morbidity than patients without. We have not observed a difference in the rate of postoperative morbidity following neoadjuvant therapy, which was also the case for Mansour et al. [9] and Fernandez et al. [21] . Gudbjartsson et al. [23] reported that induction treatment or coverage of the bronchial stump did not increase the risk of BPF and that pneumonectomy was a safe procedure with low operative mortality; neither operative mortality nor morbidity appeared to be directly associated with preoperative radiotherapy or chemotherapy. During the last decade, the postoperative mortality following pneumonectomy appeared to be lower in case of induction therapy than as in case of first-line surgery. This difference probably results from selection bias, in which only very fit patients are referred for pneumonectomy following induction therapy. We agree with Weder et al. [24] , who performed 176 pneumonectomies after neoadjuvant therapy with a 90-day postoperative mortality rate of 3% and 23 major complications occurring in 22 patients (13%), when they estimate that the need for a pneumonectomy for complete resection alone should not be a reason to exclude patients from a potentially curative procedure if done in an experienced centre. Our study has several limitations, including its retrospective design and the lack of preoperative general risk factors, including nutritional status and pulmonary function. However, the large number of patients allowed a powerful prognosis analysis. Our interpretation of the data should still be confirmed by further studies.
Despite these limits, we can conclude that the overall 90-day mortality following pneumonectomy did not change significantly during the last 30 years, but the 90-day mortality following induction therapy and pneumonectomy did significantly improve over time.
